Bristol-Myers WINS and 2 Morning Stock Stories You MUST KNOW

Bristol-Myers Squibb (NYSE:BMY) and AstraZeneca (NYSE:AZN) won the bidding war for Amylin (NASDAQ:AMLN), and will acquire the diabetes drug maker for $31 per share, giving a 10 percent windfall over Friday’s close. In total the transaction amounts to $7 billion, which includes approximately $3.4 billion from AZN, considerably increasing its diabetes collaboration with Bristol-Myers Squibb.

Airbus might be taking on Boeing (NYSE:BA), if it opens an assembly line in the U.S., which would directly challenge the latter on its home turf. Competition is rising in the world jet market, but Boeing says that Airbus would have an illegal edge, in that European governments have so far refused to remove their subsidies from that firm, and adds that any job creation by Airbus moving in are lost in other locations to the subsidies which draw business out of the U.S..

IBM’s (NYSE:IBM) says that its Intelligent Operations Center, which uses sensors and analytics software to provide city officials with the information they need in which to handle problems such as traffic, pollution, and water management, has been involved in more than 2,000 projects during the last 3 years. The software and data are hosted on IBM servers, and IOC is a part efforts to bring $7 billion in cloud-related revenues by 2015.

Featured Reading: U.S. Stock Market Pops Bubbly to Finish First Half of 2012>>